Opthea raises solvency concerns after phase 3 trial fails
--U.S. and Australia-listed biopharmaceutical firm Opthea Ltd (NASDAQ:OPT) on Monday raised concerns over its...
--U.S. and Australia-listed biopharmaceutical firm Opthea Ltd (NASDAQ:OPT) on Monday raised concerns over its...
By Melanie Burton and Divya Rajagopal MELBOURNE (Reuters) - Australia’s bourse is set for a record number of secondary listings...
-- 23Andme Holding Co (NASDAQ:ME) has filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the Eastern...
By Liz Lee BEIJING (Reuters) -China sought to reassure foreign corporate chiefs of the country’s business potential when Vice...
By Daniel Trotta (Reuters) - The U.S. government has alleged that Columbia University student and pro-Palestinian demonstrator...
-- Toyota (NYSE:TM) will postpone the construction of a lithium-ion battery plant for electric vehicles in Japan’s...
-- Jack Ma-backed Ant Group used Chinese-made semiconductors to develop less costly techniques to train artificial...
-- Malaysia is set to tighten regulations on semiconductor shipments as the U.S. pressures the country to monitor...
(Reuters) -Malaysia plans to tighten regulations on semiconductors as it comes under U.S. pressure to staunch the flow to China...
(This March 21 story has been corrected to fix the company name to Envision Group-backed AESC from Envision AESC, in paragraph...